Evidence map›Paper›PMID 29361176›Full record

ArticleNucleic acids research2018

The prolyl isomerase FKBP25 regulates microtubule polymerization impacting cell cycle progression and genomic stability.

David Dilworth, Geoff Gudavicius, Xiaoxue Xu, Andrew K J Boyce, Connor O'Sullivan, Jason J Serpa, Misha Bilenky, Evgeniy V Petrochenko, Christoph H Borchers, Martin Hirst and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Esterase D stabilizes FKBP25 to suppress mTORC1.Cellular & molecular biology letters · 2021
    Article
  8. FKBP25 Regulates Meiotic Apparatus During Mouse Oocyte Maturation.Frontiers in cell and developmental biology · 2021
    Article
  9. Article
  10. FKBP25 participates in DNA double-strand break repair.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. FKBP Ligands-Where We Are and Where to Go?Frontiers in pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

David DilworthDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada.
Geoff GudaviciusDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada.
Xiaoxue XuDivision of Medical Sciences and Island Medical Program, University of Victoria, Victoria V8P 5C2, Canada.
Andrew K J BoyceDivision of Medical Sciences and Island Medical Program, University of Victoria, Victoria V8P 5C2, Canada.
Connor O'SullivanDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada.
Jason J SerpaUniversity of Victoria Genome BC Proteomics Centre, Vancouver Island Technology Park, Victoria, BC, V8Z 7X8, Canada.
Misha BilenkyBC Cancer Agency Genome Sciences Centre and the Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Evgeniy V PetrochenkoUniversity of Victoria Genome BC Proteomics Centre, Vancouver Island Technology Park, Victoria, BC, V8Z 7X8, Canada.
Christoph H BorchersUniversity of Victoria Genome BC Proteomics Centre, Vancouver Island Technology Park, Victoria, BC, V8Z 7X8, Canada.
Martin HirstBC Cancer Agency Genome Sciences Centre and the Department of Microbiology & Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Leigh Anne SwayneDivision of Medical Sciences and Island Medical Program, University of Victoria, Victoria V8P 5C2, Canada.
Perry HowardDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada.
Christopher J NelsonDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC, V8W 3P6, Canada.
University of Victoria · CACanada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FK506 binding proteins (FKBPs) catalyze the interconversion of cis-trans proline conformers in proteins. Importantly, FK506 drugs have anti-cancer and neuroprotective properties, but the effectors and mechanisms underpinning these properties are not well understood because the cellular function(s) of most FKBP proteins are unclear. FKBP25 is a nuclear prolyl isomerase that interacts directly with nucleic acids and is associated with several DNA/RNA binding proteins. Here, we show the catalytic FKBP domain binds microtubules (MTs) directly to promote their polymerization and stabilize the MT network. Furthermore, FKBP25 associates with the mitotic spindle and regulates entry into mitosis. This interaction is important for mitotic spindle dynamics, as we observe increased chromosome instability in FKBP25 knockdown cells. Finally, we provide evidence that FKBP25 association with chromatin is cell-cycle regulated by Protein Kinase C phosphorylation. This disrupts FKBP25-DNA contacts during mitosis while maintaining its interaction with the spindle apparatus. Collectively, these data support a model where FKBP25 association with chromatin and MTs is carefully choreographed to ensure faithful genome duplication. Additionally, they highlight that FKBP25 is a MT-associated FK506 receptor and potential therapeutic target in MT-associated diseases.

Indexed as

Cell CycleCell LineDNAGenomic InstabilityHumansMicrotubulesMitosisPeptidylprolyl IsomerasePhosphorylationPolymerizationProtein Kinase CTacrolimus Binding ProteinsDNAFKBP3 protein, humanPeptidylprolyl IsomeraseProtein Kinase CTacrolimus Binding Proteins

Identifiers

PMID29361176
PMCPMC5861405
OpenAlexW2794081110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.